Newbridge Financial Services Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301K Buy
12,510
+1,426
+13% +$37.3K 0.04% 199
2026
Q1
$311K Sell
11,084
-5,806
-34% -$155K 0.05% 174
2025
Q4
$421K Buy
16,890
+2,113
+14% +$53.3K 0.07% 158
2025
Q3
$377K Sell
14,777
-5,831
-28% -$144K 0.06% 221
2025
Q2
$500K Buy
20,608
+6,174
+43% +$144K 0.08% 183
2025
Q1
$366K Sell
14,434
-470
-3% -$12.3K 0.09% 143
2024
Q4
$395K Buy
+14,904
New +$404K 0.1% 136
2024
Q3
Sell
-18,462
Closed -$517K 984
2024
Q2
$517K Buy
18,462
+3,223
+21% +$88.7K 0.19% 95
2024
Q1
$423K Sell
15,239
-2,036
-12% -$56.5K 0.18% 115
2023
Q4
$497K Buy
17,275
+2,769
+19% +$83.7K 0.24% 98
2023
Q3
$481K Buy
14,506
+2,534
+21% +$89.6K 0.24% 93
2023
Q2
$439K Sell
11,972
-581
-5% -$22.6K 0.21% 95
2023
Q1
$512K Buy
12,553
+1,041
+9% +$45K 0.27% 80
2022
Q4
$590K Sell
11,512
-133
-1% -$6.38K 0.34% 64
2022
Q3
$510K Buy
11,645
+2,540
+28% +$123K 0.3% 74
2022
Q2
$477K Buy
9,105
+756
+9% +$38.5K 0.3% 82
2022
Q1
$432K Sell
8,349
-3
-0% -$156 0.21% 101
2021
Q4
$493K Buy
8,352
+2,347
+39% +$116K 0.23% 89
2021
Q3
$258K Buy
6,005
+1,652
+38% +$73.2K 0.16% 136
2021
Q2
$170K Buy
4,353
+44
+1% +$1.71K 0.1% 200
2021
Q1
$156K Buy
4,309
+889
+26% +$31.6K 0.11% 194
2020
Q4
$126K Buy
3,420
+682
+25% +$25K 0.1% 194
2020
Q3
$95K Buy
+2,738
New +$96K 0.09% 202

Other funds holding PFE

Newbridge Financial Services Group's PFE Position: Q2 2026 in Review

Newbridge Financial Services Group increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $37.3K and bringing the position to 12,510 shares worth $301K. The position accounts for 0.04% of the portfolio, ranked #199.

Newbridge Financial Services Group first reported a position in PFE in Q3 2020 and has held it in 23 quarters since. The position peaked at $590K in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Newbridge Financial Services Group held 12,510 shares of Pfizer worth $301K as of Q2 2026.
  • Newbridge Financial Services Group bought 1,426 Pfizer shares in Q2 2026, an estimated $37.3K.
  • Pfizer made up 0.04% of Newbridge Financial Services Group's portfolio in Q2 2026, its #199 holding.
  • Newbridge Financial Services Group first reported a position in Pfizer in Q3 2020 and has held it in 23 quarters since.
  • Newbridge Financial Services Group's Pfizer position peaked at $590K in Q4 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.